The Peptide Problem MASS Research Review Exploring FDA Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP 1, GIP, GHRH, CCK, ACTH, and MSH Realms The FDA's new 503A update isn't the end of peptide therapy but it is a turning point. Several commonly used peptides are being re evaluated, with some removed from the restricted category Big FDA review coming this July. Here's what athletes and patients should know about BPC 157, TB 500, and the broader peptide conversation. Always speak with your physician before starting any new protocol. #bpc157 #